Atlantic Healthcare

Atlantic Healthcare plc is a specialty pharmaceutical company focused on developing and commercializing therapies that address unmet patient needs and rare diseases. Our current focus is on the gastrointestinal (GI) tract, targeting treatments for GI conditions that impact millions of people worldwide. We hold global exclusive rights to alicaforsen, which has the potential to establish a new class of treatment for inflammatory bowel disease (IBD) and other GI conditions.